Q1 2026 Conference Round-Up: Key Insights Across Life Sciences & Quantum

From San Diego to Denver, London to Lisbon, Q1 2026 saw our team on the ground at some of the most influential global conferences across life sciences and quantum.

And that’s not by chance.

We attend more conferences than any other life science recruitment partner.

Why? Because in a market defined by complexity, speed, and competition, the most valuable insights don’t happen on stage. They happen in hallways, over coffee, at the bar with a drink and in the conversations people don’t put into slide decks.

Face-to-face still matters. Trust is built faster. Conversations go deeper. And the insights we bring back are sharper because of it.

Momentum Returns, But Efficiency Is Everything

SCOPE Summit – Orlando, Florida

A clear shift was seen at SCOPE from caution to early-stage planning for growth, with organisations increasingly focused on execution heading into 2026.

Key trends:

• Cautious optimism returning, with budgets still controlled but forward planning increasing
• Shift toward execution and scalability over cost containment
• Operational efficiency driving leaner team structures across sponsors, CROs, and sites
• Growth in contract and flexible workforce models
• Increasing influence of PE and VC on talent and operating strategy

Hiring implications:

Rising demand for high-impact clinical operations and site professionals who can deliver quickly in lean, fast-moving environments.

Sites Expanding, Leadership Gaps Emerging, and Digital Capability Rising

SCRS Global Site Solutions Summit - Amsterdam

SCRS highlighted the rapid evolution of research sites into scalable, multi-region networks, with increasing pressure on talent and capability.

Key trends:

• Expansion of site networks into multi-country and transcontinental models (EU → US)
• Sponsors prioritising broader patient access and consistent global execution
• Ongoing gap in progression from Sub-Investigator to Principal Investigator roles
• Growing challenge for experienced PIs adapting to AI and digital trial systems
• Strong and sustained private equity interest in site networks

Hiring implications:

Demand is increasing for site leadership, clinical operations, and digitally capable investigator talent, alongside succession planning at PI level.

Clinical Research Is Reaching a Breaking Point

Site Solutions Summit (SOS) – San Diego

A clear message echoed across every session: clinical research sites are under pressure, and something has to change.

Key trends:

• Financial sustainability is under strain across research sites
• Patient recruitment remains the #1 operational bottleneck
• Technology overload is slowing site efficiency
• Workforce shortages are intensifying across key clinical roles
• Faster study start-up is now a top industry priority

Hiring implications:

Strong demand is emerging across clinical operations, regulatory, and site management roles, alongside a growing reliance on contract and flexible staffing models to maintain delivery.

Quantum Is Moving From Theory to Early Commercial Reality

APS Global Physics Summit – Denver

The conversation has shifted with quantum no longer being purely theoretical. It is increasingly focused on scalable, commercial systems.

Key trends:

• Early progress toward fault-tolerant quantum systems
• Continued hardware diversification across superconducting, ion trap, and photonic platforms
• AI is now embedded across simulation and system optimisation
• Quantum networking and sensing are gaining real traction
• Major breakthroughs in error correction and logical qubit development

Hiring implications:

Demand is increasing for highly specialised talent, including quantum error correction experts, AMO physicists, and commercially minded technical leaders.

Advanced Therapies: Optimism Returns however, Challenges Remain

Advanced Therapies – London

After a period of uncertainty, confidence is returning to cell and gene therapy, but the focus has shifted firmly toward scalability and access.

Key trends:

• Renewed investment and commercial momentum in CGT
• In vivo CAR-T emerging as a major inflection point
• Manufacturing and scalability remain the defining bottleneck
• Centralised vs decentralised manufacturing models continue to evolve
• Growing industry interest in iPSC-based therapies
• Tight funding conditions are driving sharper, more efficient innovation

Key takeaway:

The science is working, but the challenge remains how to deliver it at scale, efficiently and affordably.

Biotech Partnering Is Becoming More Selective

BIO Europe Spring – Lisbon

The partnering environment remains active, but significantly more selective and data-driven.

Key trends:

• Rising demand for niche, modality-specific commercial talent
• Strong momentum in ADCs, peptides, and complex biologics
• Continued M&A activity driven by APAC expansion
• More cautious, data-led partnering decisions
• Ongoing investment in manufacturing capacity despite market caution

Hiring implications:

Organisations are prioritising precision hiring for highly specialised roles aligned to specific modalities and growth strategies.

Investment Is Moving Earlier, Expectations Are Higher

LSX – Lisbon

The investment landscape is shifting upstream, with a sharper focus on execution and commercial clarity.

Key trends:

• Increased focus on Seed to Series B funding
• Partnerships now central to growth strategies
• AI is expected differentiation comes from impact and data quality
• Strong convergence across biotech, medtech, and digital health

Key takeaway:

Science alone is no longer enough. Commercial clarity and execution now define success.

Medical Affairs Is Now a Strategic Driver

MAPS – Denver

Medical affairs is increasingly central to strategy, not just execution.

Key trends:

• Greater integration across clinical, medical, and commercial functions
• Rapid acceleration in AI and data-driven engagement
• Expansion of omnichannel strategies
• Growth in global, cross-functional teams

Hiring implications:

Rising demand for medical strategy, HEOR, RWE, and digitally enabled medical affairs professionals.

UK Market: Quietly Competitive, Technically Focused

IAT – UK

Despite funding pressures, UK innovation remains resilient and technically strong.

Key trends:

• Continued high-quality research activity despite funding constraints
• Growing demand for in vivo and translational expertise
• Shift toward building internal capabilities rather than outsourcing

The Bigger Picture: Why This Matters

Across every conference, one theme stood out:

The pace of change is accelerating but so is complexity.

From clinical trial pressure to quantum breakthroughs and shifting investment strategies, organisations are under pressure to adapt faster than ever. And access to the right talent has never been more critical.

These insights are exactly why we show up.

You can’t get this level of understanding from LinkedIn, emails, or second-hand content.
It comes from being there, in person, having honest, unfiltered conversations with the people driving the industry forward.

That’s what turns recruiters into true market specialists.

Want to Learn More?

If you're looking to benchmark your hiring strategy, understand market movement, or access specialist talent pools across clinical, medical, commercial, or any area in the development cycle our teams are here to help.

Let’s start the conversation.